Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Management of families at high risk for hereditary breast-ovarian cancers: the endocrinologist's point of view].

Annales d'endocrinologie - 1 Jun 2008

Courtillot C, Touraine P

Abstract excerpt

Most cancers have a sporadic physiopathology, but approximately 5 to 10% of breast cancers and 10% of ovarian cancers involve a genetic predisposition. Sometimes, the gene involved in these hereditary cancers can be identified (usually BRCA1 or 2), but most of the time it remains unknown. However...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Mutation

Share to Ovarian Neoplasms

Share to PTEN Phosphohydrolase

Share to Risk Factors

Source

Identifiers

PMID: 18294609
DOI: 10.1016/j.ando.2007.12.001

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18294609-2026-09-02.1. Manifest publication-graph-cohort-2026-09-02.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Management of families at high risk for hereditary breast-ovarian cancers: the endocrinologist's point of view].PMID 18294609Read ↗

[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer].Semantic proximity Read ↗

[Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families].Semantic proximity Read ↗

[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].Semantic proximity Read ↗

ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.Semantic proximity Read ↗

[Inherited breast and ovarian cancers].Semantic proximity Read ↗

[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary].Semantic proximity Read ↗

[BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer].Semantic proximity Read ↗

[Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers].Semantic proximity Read ↗

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.Semantic proximity Read ↗

[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer].Semantic proximity Read ↗

[In cases of familial ovarian cancer, always consider the risk of breast cancer].Semantic proximity Read ↗

[Peculiarities of diagnosis, treatment and prevention of hereditary cancer of the breast and ovary. Clinical and genetic screening among BRCA1/2 mutation carriers and individuals with high family risk of cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.